|
|
楼主 |
发表于 2025-1-9 17:21:59
|
显示全部楼层
还统计少了，华西医院牵头是25项
: T8 s9 d4 H# \' y, k01.Risk factors of complications after inguinal lymph node dissection in patients with penile cancer.& M. [8 U' j/ ` L. g
02.Tislelizumab in combination with abiraterone/enzalutamide for metastatic castration-resistant prostate cancer with intraductal adenocarcinoma of the prostate after progression on prior androgen receptor pathway inhibitor./ K- T5 S% O ]% h( G9 q, h
03.Discordance in HER2 expression in primary and recurrent/metastatic lesions of upper tract urothelial carcinoma: A study focusing on temporal heterogeneity.; n& u; `9 V, t/ k- q6 U0 e4 t
04.The impact of neoadjuvant therapy on the formation of tertiary lymphatic structures and the distinct prognosis in prostate cancer.
/ C3 [8 U+ W: C5 e; [3 J( H' x05.Phenotypic and genetically predicted leukocyte telomere length and prostate cancer risk: Results from a large-scale longitudinal cohort study.
f1 b) L2 d/ K* v% P. k06.Survival impact of concomitant squamous differentiation in upper tract urothelial carcinoma patients receiving adjuvant chemotherapy.% ?6 {3 k' ]+ M( m1 Z
07.Pathological subclassification of T3 upper tract urothelial carcinoma: Complementary evidence for existing guidelines.' E3 _. d/ C! b" R% R$ G! N1 Y
08.Evaluating the efficacy and safety of pelvic lymph node dissection in high-risk prostate cancer patients undergoing radical prostatectomy: A systematic review and meta-analysis.1 {6 E* x9 F% \, `
09.Safety and efficacy of immune checkpoint inhibitor rechallenge in metastatic fumarate hydratase-deficient renal cell carcinoma: A retrospective study.
: o" D$ r9 E: x1 J10.Interpretable machine learning for prostate biopsy: Cohort study.
9 b& S; F4 f, E3 a, G$ e! C( A11.Genomic features of prostate cancer patients with and without ductal adenocarcinoma (DA) based on liquid biopsy.0 n9 S5 g/ D0 T; u
12.Clinicopathological features and prognosis of MED15-TFE3 rearrangement renal cell carcinoma: An updated report.4 e0 q0 _1 H! t+ ^5 B, D: w( e2 E
13.Long-term results of a phase 2 study of neoadjuvant chemotherapy combined with tislelizumab followed by radiotherapy for bladder-preserving treatment in selected high-risk/locally advanced muscle invasive urothelial bladder cancer (HOPE-02).# L- ]5 T* S$ `. c3 h$ S2 N# Q
14.A multi-center phase Ib/II study of RC48-ADC combined with tislelizumab as neoadjuvant treatment in patients with HER2 positive locally advanced muscle-invasive urothelial bladder cancer (Hope-03).
* s$ r1 R, c/ [, }% s15.VORSIN-RCC: Vorolanib plus sintilimab for advanced renal cell carcinoma after failure of prior immune checkpoint inhibitors-based combination therapy.
/ `. m) N: h! C6 g9 s% i) C- G& z* ]16.Cadonilimab (anti-PD-1 and CTLA-4 bispecific antibody) combined with axitinib for the first-line treatment of advanced or metastatic non-clear renal cell carcinoma: A prospective, single-arm, phase Ib/II study.
& H7 Y t. w% H: X: n17.Kidney-sparing approach for selected localized high-risk upper tract urothelial carcinoma: A pilot study combining endoscopic thulium laser ablation with perioperative disitamab vedotin and immune checkpoint inhibitors.
$ G" c$ ^5 ~: w0 f% q% H& y. c& e18.Comprehensive modalities of kidney-sparing treatment in a carefully selected cohort of localized high-risk upper tract urothelial carcinoma: A potential paradigm shift.( H, |+ k* w# Z9 y
19.Efficacy of systemic treatments for advanced non-clear cell renal cell carcinoma: A single-arm systematic review and meta-analysis.( b4 T. h+ M' x0 Y9 y% F) z7 |
20.The prognostic significance of prostate-specific antigen dynamics during abiraterone therapy in patients with high-risk metastatic hormone-sensitive prostate cancer.
" @! v8 Z F- w; Z9 B; w4 c* G21.Global spatiotemporal trends in prostate cancer burden and its socioeconomic disparities: An observational study from 1990 to 2021.
3 I! J* L$ k% b* ~3 R A' M( e; f9 e22.Optimizing the strategies to perform prostate biopsy in MRI-positive patients: A systematic review and network meta-analysis./ w3 {( I- o% a
23.Assessment of the proficiency of ChatGPT-4o in an image-based robot-assisted radical prostatectomy scenario.7 G5 z$ m8 R; @
24.The prognostic significance of circulating tumor DNA in prostate cancer: A systematic review and meta-analysis.
2 s4 c$ x) G/ @# Q, Y# n25.Global and regional burden of kidney cancer: Analysis and future predictions based on GBD data from 1990 to 2021.
}" Y4 a* t; ?6 A; }% } |
|
发表于 2025-1-9 15:59:44
发表于 2025-1-9 17:01:32
看年内重离子质子医院投运后，能否发起追赶
